Cargando…
Bromocriptine treatment associated with recovery from peripartum cardiomyopathy in siblings: two case reports
INTRODUCTION: Peripartum cardiomyopathy is a rare form of cardiomyopathy, with heterogeneous presentation occurring in women between one-month antepartum and six months postpartum. It carries a poor prognosis and a high risk of mortality. CASE PRESENTATION: We report the development of peripartum ca...
Autores principales: | Meyer, Gerd Peter, Labidi, Saida, Podewski, Edith, Sliwa, Karen, Drexler, Helmut, Hilfiker-Kleiner, Denise |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2839987/ https://www.ncbi.nlm.nih.gov/pubmed/20202212 http://dx.doi.org/10.1186/1752-1947-4-80 |
Ejemplares similares
-
Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study
por: Hilfiker-Kleiner, Denise, et al.
Publicado: (2017) -
Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction
por: Haghikia, Arash, et al.
Publicado: (2018) -
Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy
por: Haghikia, Arash, et al.
Publicado: (2015) -
Complete recovery of fulminant peripartum cardiomyopathy on mechanical circulatory support combined with high‐dose bromocriptine therapy
por: Horn, Patrick, et al.
Publicado: (2017) -
Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy
por: Haghikia, A., et al.
Publicado: (2013)